Techne Newswire

Comprehensive Real-Time News Feed for Techne.

Results 1 - 20 of 40 in Techne

  1. Bio-Techne Launches Simple Plex PlatformRead the original story

    Thursday Jan 22 | Freshnews

    Bio-Techne Corporation announced today that it has launched Ella , the first member of the new Simple Plex platform through its Proteins Platform division under the ProteinSimple brand. This launch represents the re-branding of the previously acquired CyPlex instrument platform from CyVek.

    Comment?

  2. BIO-TECHNE Corp Stock Rating Upgraded by ZacksRead the original story

    Monday Jan 19 | AmericanBankingNews.com

    ... of 4.77% from the company's current price. Separately, analysts at Janney Montgomery Scott upgraded shares of BIO-TECHNE Corp from a "neutral" rating to a "buy" rating in a research note on Wednesday, December 10th. One investment analyst has rated ...

    Comment?

  3. Now Available: Bio-Techne (TECH) - Medical Equipment - Deals and Alliances ProfileRead the original story

    Friday Jan 2 | PR-inside.com

    ... 20:00:40 - New Medical Devices research report from GlobalData is now available from Fast Market Research Bio-Techne is a holding company. The company develops, produces and sells biotechnology products and hematology products. It operates through ...

    Comment?

  4. Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms DivisionRead the original story

    Nov 25, 2014 | Freshnews

    Bio?Techne Corporation announced today that it has appointed Robert Gavin to serve in a newly created position of Senior Vice President of the Protein Platforms Division. Mr. Gavin will be responsible for managing the operations of Bio?Techne's Protein Platforms business segment, which includes the ProteinSimple business acquired in July 2014 and the recently acquired CyVek business.

    Comment?

  5. Bio-Techne buys Conn. testing-equipment firm for $60 millionRead the original story w/Photo

    Nov 4, 2014 | Star Tribune

    Several months ahead of schedule, Bio-Techne Corp. has agreed to acquire Connecticut's CyVek for $60 million in cash and debt, plus future payments if revenue targets are achieved. Minneapolis -based Bio-Techne -- which recently rebranded itself from its old name, Techne Corp. -- announced Tuesday that it agreed to the deal after CyVek's biomedical-analysis system CyPlex demonstrated its clinical effectiveness earlier than had been expected.

    Comment?

  6. Bio-Techne to acquire CyVek for $60MRead the original story w/Photo

    Nov 4, 2014 | Medical News

    Bio-Techne Corporation announced today that it has agreed to acquire CyVek, Inc. for $60 million in cash, plus a potential earn-out payment of up to $35 million based on CyVek revenue over the 30-month period following the closing and an additional potential earn-out payment based on CyVek revenue through 2020 in excess of $100 million. The closing of the acquisition is the result of CyVek having met pre-agreed commercial milestones.

    Comment?

  7. Bio-Techne Pays $60 Million For CyVekRead the original story

    Nov 4, 2014 | BioSpace

    ... research and clinical applications. The CyPlexTM technology has the potential for broad market applicability. Bio-Techne is a leading developer and manufacturer of purified proteins, notably cytokines and growth factors, antibodies, immunoassays and ...

    Comment?

  8. Renovation Row sale: ProteinSimple building flips to American Realty for big markupRead the original story w/Photo

    Oct 30, 2014 | Business Journal

    One reason, of course, is that the building is now leased, after Ridge and Contrarian pumped money into a renovation of the building. As I wrote back in May, protein analysis company ProteinSimple leased the entire space , shortly before it was bought by Techne Corp. The ProteinSimple deal was the second significant lease this year of renovated space on the Orchard Parkway corridor, where investors such as M West, Lane Partners, Ellis Partners, Bixby Land Co.

    Comment?

  9. Techne Shares Down 4.6% on Disappointing EarningsRead the original story

    Oct 28, 2014 | AmericanBankingNews.com

    Techne shares fell 4.6% on Tuesday after the company announced weaker than expected quarterly earnings, Stock Ratings News reports. The company traded as low as $88.28 and last traded at $89.99, with a volume of 97,527 shares traded.

    Comment?

  10. Techne's (TECH) CEO, Charles Kummeth on Q1 2015 Results - Earnings Call TranscriptRead the original story w/Photo

    Oct 28, 2014 | Seeking Alpha

    Good morning and welcome to the Bio-Techne earnings conference call for the first quarter of the full fiscal year 2015. At this time, all participants have been placed in a listen-only mode and the floor will be open for questions following management's prepared remarks.

    Comment?

  11. Techne (TECH) Set to Announce Quarterly Earnings on TuesdayRead the original story

    Oct 27, 2014 | AmericanBankingNews.com

    Techne is scheduled to be issuing its Q115 quarterly earnings data on Tuesday, October 28th. Analysts expect the company to announce earnings of $0.87 per share and revenue of $108.65 million for the quarter.

    Comment?

  12. Techne Corp. Release: To Host Conference Call On October 28, 2014 To...Read the original story

    Oct 21, 2014 | BioSpace

    Techne Corp. Release: Bio-Techne To Host Conference Call On October 28, 2014 To Announce First Quarter Financial Results /PRNewswire/ -- Techne Corporation , d/b/a Bio-Techne, today announced that management will host a conference call on A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by going to: Techne Corporation , , is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases.

    Comment?

  13. New Market Report: Bio-Techne (TECH) - Financial and Strategic SWOT Analysis ReviewRead the original story

    Sep 6, 2014 | PR-inside.com

    This comprehensive SWOT profile of Bio-Techne provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats.

    Comment?

  14. MobileIron granted two new patentsRead the original story

    Sep 3, 2014 | Theflyonthewall.com

    ... information classification. On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: Bio-Techne (TECH) initiated with an Overweight at Stephens... Culp (CFI) initiated with a Buy at Stifel... MobileIron (MOBL) initiated with an ...

    Comment?

  15. Techne Corp. Hits New 12-Month High at $97.15Read the original story

    Sep 2, 2014 | AmericanBankingNews.com

    Techne Corp. hit a new 52-week high on Tuesday , AmericanBankingNews.com reports.

    Comment?

  16. MRC Technology Negotiates License With For s GOPAL Protein Synthesis TechnologyRead the original story

    Aug 26, 2014 | BioSpace

    Technology enables production of ubiquitin reagents and other proteins for use in drug discovery London, UK, 26th August 2014: MRC Technology, a technology transfer organisation, today announced it has negotiated a licence for a protein synthesis technology, Genetically encoded Orthogonal Protection and Activated Ligation , with Bio-Techne, , a ... (more)

    Comment?

  17. Techne Corp. Receives New Coverage from Analysts at StephensRead the original story

    Aug 22, 2014 | AmericanBankingNews.com

    In other Techne Corp. news, Director Karen A. Holbrook unloaded 5,000 shares of Techne Corp. stock in a transaction that occurred on Thursday, August 14th.

    Comment?

  18. On The Fly: Analyst Initiation SummaryRead the original story

    Aug 11, 2014 | Theflyonthewall.com

    On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: Bio-Techne initiated with an Overweight at Stephens... Culp initiated with a Buy at Stifel... MobileIron initiated with an Outperform at Imperial Capital... NanoString management to meet with Piper Jaffray... SuperCom initiated with an Outperform at Imperial Capital.

    Comment?

  19. Techne Corp. Director Unloads $477,700 in StockRead the original story

    Aug 17, 2014 | AmericanBankingNews.com

    Techne Corp. Director Karen A. Holbrook unloaded 5,000 shares of the stock on the open market in a transaction dated Thursday, August 14th.

    Comment?

  20. Insider Selling: Techne Corp. Director Sells 5,000 Shares of StockRead the original story

    Aug 15, 2014 | AmericanBankingNews.com

    Techne Corp. Director Karen A. Holbrook sold 5,000 shares of Techne Corp. stock on the open market in a transaction dated Thursday, August 14th.

    Comment?